BMJ Open (Sep 2024)

Actioning atrial fibrillation identified by ambulance services in England: a qualitative exploration

  • Tim Doran,
  • Chris Wilkinson,
  • Christopher Price,
  • Susan Moloney,
  • Adam Todd,
  • Graham McClelland

DOI
https://doi.org/10.1136/bmjopen-2023-078777
Journal volume & issue
Vol. 14, no. 9

Abstract

Read online

Objectives To explore the acceptability and feasibility of detection of atrial fibrillation (AF) by emergency medical services (EMS) and identify potential barriers and facilitators to implementing a formal pathway to facilitate follow-up in primary care, which could reduce the risk of AF-related stroke.Design Qualitative study using focus groups and one-to-one interviews guided by a semistructured topic guide.Setting North East England.Participants Focus groups with 18 members of the public and one-to-one online interviews with 11 healthcare and service providers (six paramedics and five experts representing cardiology, general practice (GP), public health, research, policy and commissioning).Results All participant groups were supportive of a role of EMS in identifying AF as part of routine assessment and formalising the response to AF detection. However, this should not create delays for EMS since rate-controlled AF is non-urgent and alternative community mechanisms exist to manage it. Public participants were concerned about communication of the AF diagnosis and whether this should be ‘on scene’ or in a subsequent GP appointment. Paramedics reported frequent incidental identification of AF, but it is not always clear ‘on scene’ that this is a new diagnosis, and there is variation in practice regarding whether (and how) this is communicated to the GP. Paramedics also focused on ensuring the safety of non-conveyed patients and a perceived need for an ‘active’ reporting process, so that a finding of AF was actioned. Field experts felt that a formal pathway would be useful and favoured a simple intervention without adding to time pressures unnecessarily.Conclusions There is support for the development of a formal pathway to ensure follow-up for people with AF that is incidentally detected by EMS. This has the potential to improve anticoagulation rates and reduce the risk of stroke.